Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease

被引:5
|
作者
Cruz, Nelly M. [1 ,2 ,3 ,4 ]
Song, Xuewen [5 ,6 ]
Czerniecki, Stefan M. [1 ,2 ,3 ,4 ]
Gulieva, Ramila E. [1 ,2 ,3 ,4 ]
Churchill, Angela J. [1 ,2 ,3 ,4 ]
Kim, Yong Kyun [1 ,2 ,3 ,4 ]
Winston, Kosuke [1 ,2 ,3 ,4 ]
Tran, Linh M. [1 ,2 ,3 ,4 ]
Diaz, Marco A. [1 ,2 ,3 ,4 ]
Fu, Hongxia [3 ,4 ,7 ,8 ]
Finn, Laura S. [9 ,10 ]
Pei, York [5 ,6 ]
Himmelfarb, Jonathan [1 ,2 ,4 ]
Freedman, Benjamin S. [1 ,2 ,3 ,4 ]
机构
[1] Univ Washington, Sch Med, Div Nephrol, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Kidney Res Inst, Seattle, WA 98109 USA
[3] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA
[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98109 USA
[5] Univ Hlth Network, Div Nephrol, Toronto, ON M5G2N2, Canada
[6] Univ Toronto, Toronto, ON M5G 2N2, Canada
[7] Univ Washington, Sch Med, Div Hematol, Dept Med, Seattle, WA 98109 USA
[8] Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98109 USA
[9] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98109 USA
[10] Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105 USA
关键词
PLURIPOTENT STEM-CELLS; CYST FORMATION; PKD1; GENE; EXPRESSION; INJURY; VASOPRESSIN; INHIBITION; APOPTOSIS; GROWTH;
D O I
10.1038/NMAT4994
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Polycystic kidney disease (PKD) is a life-threatening disorder, commonly caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form fluid-filled cysts(1,2). A major barrier to understanding PKD is the absence of human cellular models that accurately and effciently recapitulate cystogenesis(3,4). Previously, we have generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids(5,6). Here we show that systematic substitution of physical components can dramatically increase or decrease cyst formation, unveiling a critical role for microenvironment in PKD. Removal of adherent cues increases cystogenesis 10-fold, producing cysts phenotypically resembling PKD that expand massively to 1-centimetre diameters. Removal of stroma enables outgrowth of PKD cell lines, which exhibit defects in PC1 expression and collagen compaction. Cyclic adenosine monophosphate (cAMP), when added, induces cysts in both PKD organoids and controls. These biomaterials establish a highly effcient model of PKD cystogenesis that directly implicates the microenvironment at the earliest stages of the disease.
引用
收藏
页码:1112 / +
页数:10
相关论文
共 50 条
  • [31] Inhibition of Cdc25A Suppresses Hepato-renal Cystogenesis in Rodent Models of Polycystic Kidney and Liver Disease
    Masyuk, Tatyana V.
    Radtke, Brynn N.
    Stroope, Angela J.
    Banales, Jesus M.
    Masyuk, Anatoliy I.
    Gradilone, Sergio A.
    Gajdos, Gabriella Bedekovicsne
    Chandok, Natasha
    Bakeberg, Jason L.
    Ward, Christopher J.
    Ritman, Erik L.
    Kiyokawa, Hiroaki
    LaRusso, Nicholas F.
    GASTROENTEROLOGY, 2012, 142 (03) : 622 - U310
  • [32] The mTOR Pathway Is Activated in Human Autosomal-Recessive Polycystic Kidney Disease
    Becker, Jan Ulrich
    Saez, Anabelle Opazo
    Zerres, Klaus
    Witzke, Oliver
    Hoyer, Peter Friedrich
    Schmid, Kurt Werner
    Kribben, Andreas
    Bergmann, Carsten
    Nuernberger, Jens
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (02) : 129 - 138
  • [33] Pathogenesis of autosomal dominant polycystic kidney disease: Role of apoptosis
    Zhou, XJ
    Kukes, G
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (02) : 65 - 68
  • [34] Polycystic kidney disease-like domains of clostridial collagenases and their role in collagen recruitment
    Eckhard, Ulrich
    Brandstetter, Hans
    BIOLOGICAL CHEMISTRY, 2011, 392 (11) : 1039 - 1045
  • [35] Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease
    Magayr, Tajdida A.
    Song, Xuewen
    Streets, Andrew J.
    Vergoz, Laura
    Chang, Lijun
    Valluru, Manoj K.
    Yap, Hsiu L.
    Lannoy, Morgane
    Haghighi, Amirreza
    Simms, Roslyn J.
    Tam, Frederick W. K.
    Pei, York
    Ong, Albert C. M.
    KIDNEY INTERNATIONAL, 2020, 98 (02) : 420 - 435
  • [36] Randomized Intervention Studies in Human Polycystic Kidney and Liver Disease
    Schrier, Robert W.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (06): : 891 - 893
  • [37] cAMP-Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease
    Mi, Zeyun
    Song, Yandong
    Wang, Jiuchen
    Liu, Zhiheng
    Cao, Xinyi
    Dang, Lin
    Lu, Yumei
    Sun, Yongzhan
    Xiong, Hui
    Zhang, Lirong
    Chen, Yupeng
    ADVANCED SCIENCE, 2022, 9 (10)
  • [38] Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
    Podrini, Christine
    Rowe, Isaline
    Pagliarini, Roberto
    Costa, Ana S. H.
    Chiarayalli, Marco
    Di Meo, Ivano
    Kim, Hyunho
    Distefano, Gianfranco
    Tiranti, Valeria
    Qian, Feng
    di Bernardo, Diego
    Frezza, Christian
    Boletta, Alessandra
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [39] THE ROLE OF MTOR INHIBITION IN THE CONTROL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Perico, N.
    Remuzzi, G.
    DRUGS OF THE FUTURE, 2010, 35 (11) : 929 - 938
  • [40] Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins
    Lan, Qiumei
    Li, Jie
    Zhang, Hanqing
    Zhou, Zijun
    Fang, Yaxuan
    Yang, Bo
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2024, 102 (06): : 773 - 785